Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish initial safety, tolerability, pharmacokinetics and
pharmacodynamics of MYK-461 in human subjects. This is a sequential group, single ascending
(oral) dose study in NYHA Class I, II, or III patient volunteers aged 18-65 years.